Comparison of Hepatocellular Markers for Diagnosis of Poorly-Differentiated Hepatocellular Carcinoma: High Sensitivity with Combined Use of Arginase-1 and Glypican-3

被引：0
|
作者：
Phillips, D. G. K.
Jain, D.
Torbenson, M.
Wu, T-T
Yeh, M. M. C.
Kakar, S.
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Yale New Haven Med Ctr, New Haven, CT 06504 USA
[3] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
[4] Mayo Clin, Rochester, MN USA
[5] Univ Washington, Seattle, WA 98195 USA
来源：
LABORATORY INVESTIGATION | 2012年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1760
引用
收藏
页码：422A / 422A
页数：1
相关论文
共 50 条
  • [41] Photoimmunotherapy of hepatocellular carcinoma-targeting Glypican-3 combined with nanosized albumin-bound paclitaxel
    Hanaoka, Hirofumi
    Nakajima, Takahito
    Sato, Kazuhide
    Watanabe, Rira
    Phung, Yen
    Gao, Wei
    Harada, Toshiko
    Kim, Insook
    Paik, Chang H.
    Choyke, Peter L.
    Ho, Mitchell
    Kobayashi, Hisataka
    NANOMEDICINE, 2015, 10 (07) : 1139 - 1147
  • [42] Glypican-3 as a potential differential diagnosis marker for hepatocellular carcinoma: A tissue microarray-based study
    Zhang, Lijie
    Liu, Hui
    Sun, Lin
    Li, Ning
    Ding, Huiguo
    Zheng, Jie
    ACTA HISTOCHEMICA, 2012, 114 (06) : 547 - 552
  • [43] Diagnosis Accuracy of Serum Glypican-3 in Patients with Hepatocellular Carcinoma: A Systematic Review with Meta-analysis
    Jia, Xiaobo
    Liu, Jiao
    Gao, Yingtang
    Huang, Yong
    Du, Zhi
    ARCHIVES OF MEDICAL RESEARCH, 2014, 45 (07) : 580 - 588
  • [44] Development of a Time-Resolved Fluorescence Immunoassay for the Diagnosis of Hepatocellular Carcinoma Based on the Detection of Glypican-3
    Juan-Juan Chen
    Chun-Mei Xie
    Cong-Rong Wang
    Yong Wan
    Zhi-Ning Dong
    Ming Li
    Wei-Wen Xu
    Journal of Fluorescence, 2017, 27 : 1479 - 1485
  • [45] Golgi protein 73, not Glypican-3, may be a tumor marker complementary to α-Fetoprotein for hepatocellular carcinoma diagnosis
    Wang, Yichen
    Yang, Huayu
    Xu, Haifeng
    Lu, Xin
    Sang, Xinting
    Zhong, Shouxian
    Huang, Jiefu
    Mao, Yilei
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (03) : 597 - 602
  • [46] Development of a Time-Resolved Fluorescence Immunoassay for the Diagnosis of Hepatocellular Carcinoma Based on the Detection of Glypican-3
    Chen, Juan-Juan
    Xie, Chun-Mei
    Wang, Cong-Rong
    Wan, Yong
    Dong, Zhi-Ning
    Li, Ming
    Xu, Wei-Wen
    JOURNAL OF FLUORESCENCE, 2017, 27 (04) : 1479 - 1485
  • [47] Glypican-3 expression in benign liver tissue with active hepatitis C: implications for the diagnosis of hepatocellular carcinoma
    Abdul-Al, Hala M.
    Makhlouf, Hala R.
    Wang, Guanghua
    Goodman, Zachary D.
    HUMAN PATHOLOGY, 2008, 39 (02) : 209 - 212
  • [48] Can Serum Glypican-3 Be a Biomarker for Effective Diagnosis of Hepatocellular Carcinoma? A Meta-Analysis of the Literature
    Yang, Sheng-Li
    Fang, Xiefan
    Huang, Zao-Zao
    Liu, Xiang-Jie
    Xiong, Zhi-Fan
    Liu, Ping
    Yao, Hong-Yi
    Li, Chang-Hai
    DISEASE MARKERS, 2014, 2014
  • [49] A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis
    Cheng Xu
    Zhehui Yan
    Liang Zhou
    Yuming Wang
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 1417 - 1424
  • [50] A comparison of glypican-3 with alpha-fetoprotein as a serum marker for hepatocellular carcinoma: a meta-analysis
    Xu, Cheng
    Yan, Zhehui
    Zhou, Liang
    Wang, Yuming
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2013, 139 (08) : 1417 - 1424
12345